Evaluation of combined biomarker in response to immunotherapy (I/O) in patients with advanced non-small cell lung cancer (NSCLC)

H. O. Ramdani; S. Shatz; M. Falk; L. C. Heukamp; M. Tiemann; C. Wesseler; E. Schuuring; H. J. Groen; F. Griesinger

Evaluation of combined biomarker in response to immunotherapy (I/O) in patients with advanced non-small cell lung cancer (NSCLC)

H. O. Ramdani, S. Shatz, M. Falk, L. C. Heukamp, M. Tiemann, C. Wesseler, E. Schuuring, H. J. Groen, F. Griesinger

Onderzoeksoutput: Meeting Abstract › Academic

Originele taal-2	English
Pagina's (van-tot)	153-153
Aantal pagina's	1
Tijdschrift	Oncology Research and Treatment
Volume	43
Nummer van het tijdschrift	SUPPL 4
Status	Published - okt-2020

Citeer dit

@article{a95d39f79d2c4d609984d0812dd3be8f,

title = "Evaluation of combined biomarker in response to immunotherapy (I/O) in patients with advanced non-small cell lung cancer (NSCLC)",

author = "Ramdani, {H. O.} and S. Shatz and M. Falk and Heukamp, {L. C.} and M. Tiemann and C. Wesseler and E. Schuuring and Groen, {H. J.} and F. Griesinger",

year = "2020",

month = oct,

language = "English",

volume = "43",

pages = "153--153",

journal = "Oncology Research and Treatment",

issn = "2296-5270",

publisher = "KARGER",

number = "SUPPL 4",

}

Evaluation of combined biomarker in response to immunotherapy (I/O) in patients with advanced non-small cell lung cancer (NSCLC). / Ramdani, H. O.; Shatz, S.; Falk, M.; Heukamp, L. C.; Tiemann, M.; Wesseler, C.; Schuuring, E.; Groen, H. J.; Griesinger, F.

In: Oncology Research and Treatment, Vol. 43, Nr. SUPPL 4, 10.2020, blz. 153-153.

Onderzoeksoutput: Meeting Abstract › Academic

TY - JOUR

T1 - Evaluation of combined biomarker in response to immunotherapy (I/O) in patients with advanced non-small cell lung cancer (NSCLC)

AU - Ramdani, H. O.

AU - Shatz, S.

AU - Falk, M.

AU - Heukamp, L. C.

AU - Tiemann, M.

AU - Wesseler, C.

AU - Schuuring, E.

AU - Groen, H. J.

AU - Griesinger, F.

PY - 2020/10

Y1 - 2020/10

M3 - Meeting Abstract

VL - 43

SP - 153

EP - 153

JO - Oncology Research and Treatment

JF - Oncology Research and Treatment

SN - 2296-5270

IS - SUPPL 4

ER -